SCHEMBL3215910

SCHEMBL3215910

FC(F)(F)C1(F)C(F)(F)C(F)(C(F)(F)F)C(F)(C(F)(F)F)C(F)(C(F)(F)F)C1(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9301843 0.92
SCHEMBL62640 0.92
SCHEMBL6407710 0.92
SCHEMBL5395187 0.92
SCHEMBL3214827 0.92
SCHEMBL3217827 0.88
SCHEMBL12506200 0.85 MEN1 (0.31)
SCHEMBL33642 0.85 MEN1 (0.31)
SCHEMBL33634 0.84
SCHEMBL1271146 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2198869-B1 TREHALOSE FOR THE TREATMENT OR PREVENTION OF VASOSPASM NEXT 21 K K (JP) 2015-09-16 EP disclosed
US-8283337-B2 Therapeutic or prophylactic agent for vasoconstriction NEXT21 K.K. (JP) 2012-10-09 US disclosed
EP-2198869-A1 THERAPEUTIC OR PROPHYLACTIC AGENT FOR VASOCONSTRICTION Next 21 K.K. (JP) 2010-06-23 EP disclosed
US-20100035837-A1 THERAPEUTIC OR PROPHYLACTIC AGENT FOR VASOCONSTRICTION NEXT21 K.K. (JP) 2010-02-11 US disclosed